Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing
Sign Up to like & getrecommendations! Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.25713
Abstract: Mebendazole (MBZ) was recently shown to induce a tumor suppressive M1 phenotype in THP-1 monocytes and macrophages. In the present study the immune effects of MBZ was further investigated using human peripheral blood mononuclear cells… read more here.
Keywords: tumour cell; cell; cell killing; stimulates cd14 ... See more keywords